FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2535014722> ?p ?o ?g. }

• W2535014722 endingPage "2476" @default.
• W2535014722 startingPage "2468" @default.
• W2535014722 abstract "Purpose Case reports of treatment failure with standard-dose daptomycin (6 mg/kg) have recently surfaced in vancomycin-resistant Enterococcus (VRE) bloodstream infection (BSI) episodes with daptomycin MICs of 3 to 4 mg/L. The clinical implications of daptomycin MICs of 3 to 4 mg/L in VRE BSIs have not been elucidated. Methods We performed a single institutional retrospective analysis of adult stem cell transplant recipients and patients with hematologic malignancies diagnosed with VRE BSI from 2006 to 2014 and compared outcomes between those with daptomycin MICs of 3 to 4 mg/L those with 2 mg/L, as determined by Etest. Findings Forty-two daptomycin-treated VRE BSI episodes, all due to Enterococcus faecium were identified; 19 episodes with daptomycin MICs of 3 to 4 mg/L and 23 episodes with a daptomycin MIC of 2 mg/L. Patients in the higher daptomycin MIC group were more likely to be male, to be stem cell transplant recipients, and to have received high-dose daptomycin treatment (>6 mg/kg). In unadjusted analyses, microbiological failure in the daptomycin MICs 3 to 4 mg/L versus 2 mg/L groups (odds ratio = 1.79, 95% CI, 0.52–6.11; P = 0.35), the median duration of bacteremia (4 days in daptomycin MICs 3–4 mg/L vs 3 days in daptomycin MIC 2 mg/L; P = 0.18) and all-cause 30-day mortality (21% in daptomycin MICs 3–4 mg/L vs 35% in daptomycin MIC 2 mg/L group; P = 0.49) were not different. In adjusted analyses, the association between higher Pitt bacteremia scores and all-cause 30-day mortality was statistically significant (P = 0.0006), whereas the association between daptomycin MICs of 3 to 4 mg/L and all-cause 30-day mortality approached statistical significance (P = 0.06). Implications Duration of bacteremia and microbiological failure rates did not differ by daptomycin MICs in VRE BSI episodes in our patients, composed of adult stem cell transplant recipients and patients with hematologic malignancies. There was a nonsignificant trend in multivariable analysis suggesting that all-cause 30-day mortality was lower in patients whose VRE bloodstream isolates were with daptomycin MICs of 3 to 4 mg/L." @default.
• W2535014722 created "2016-10-28" @default.
• W2535014722 creator A5003850875 @default.
• W2535014722 creator A5025478600 @default.
• W2535014722 creator A5033818354 @default.
• W2535014722 creator A5053291056 @default.
• W2535014722 creator A5056245742 @default.
• W2535014722 creator A5062115308 @default.
• W2535014722 creator A5067410838 @default.
• W2535014722 creator A5068286313 @default.
• W2535014722 date "2016-11-01" @default.
• W2535014722 modified "2023-09-23" @default.
• W2535014722 title "Vancomycin-resistant Enterococcal Bloodstream Infections in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies: Impact of Daptomycin MICs of 3 to 4 mg/L" @default.
• W2535014722 cites W1807942347 @default.
• W2535014722 cites W1903794280 @default.
• W2535014722 cites W1974903759 @default.
• W2535014722 cites W2001280008 @default.
• W2535014722 cites W2003332789 @default.
• W2535014722 cites W2014105082 @default.
• W2535014722 cites W2015334010 @default.
• W2535014722 cites W2026693802 @default.
• W2535014722 cites W2040010886 @default.
• W2535014722 cites W2041215841 @default.
• W2535014722 cites W2050939778 @default.
• W2535014722 cites W2053739788 @default.
• W2535014722 cites W2096073113 @default.
• W2535014722 cites W2097259039 @default.
• W2535014722 cites W2107978429 @default.
• W2535014722 cites W2112459888 @default.
• W2535014722 cites W2121121756 @default.
• W2535014722 cites W2129864306 @default.
• W2535014722 cites W2130824753 @default.
• W2535014722 cites W2135114811 @default.
• W2535014722 cites W2139305990 @default.
• W2535014722 cites W2146341069 @default.
• W2535014722 cites W2157744708 @default.
• W2535014722 cites W2166940218 @default.
• W2535014722 cites W2336542238 @default.
• W2535014722 doi "https://doi.org/10.1016/j.clinthera.2016.09.011" @default.
• W2535014722 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27771176" @default.
• W2535014722 hasPublicationYear "2016" @default.
• W2535014722 type Work @default.
• W2535014722 sameAs 2535014722 @default.
• W2535014722 citedByCount "17" @default.
• W2535014722 countsByYear W25350147222017 @default.
• W2535014722 countsByYear W25350147222018 @default.
• W2535014722 countsByYear W25350147222019 @default.
• W2535014722 countsByYear W25350147222020 @default.
• W2535014722 countsByYear W25350147222021 @default.
• W2535014722 countsByYear W25350147222022 @default.
• W2535014722 crossrefType "journal-article" @default.
• W2535014722 hasAuthorship W2535014722A5003850875 @default.
• W2535014722 hasAuthorship W2535014722A5025478600 @default.
• W2535014722 hasAuthorship W2535014722A5033818354 @default.
• W2535014722 hasAuthorship W2535014722A5053291056 @default.
• W2535014722 hasAuthorship W2535014722A5056245742 @default.
• W2535014722 hasAuthorship W2535014722A5062115308 @default.
• W2535014722 hasAuthorship W2535014722A5067410838 @default.
• W2535014722 hasAuthorship W2535014722A5068286313 @default.
• W2535014722 hasBestOaLocation W25350147222 @default.
• W2535014722 hasConcept C126322002 @default.
• W2535014722 hasConcept C141071460 @default.
• W2535014722 hasConcept C2777677444 @default.
• W2535014722 hasConcept C2778651397 @default.
• W2535014722 hasConcept C2778980435 @default.
• W2535014722 hasConcept C2779443120 @default.
• W2535014722 hasConcept C2779489039 @default.
• W2535014722 hasConcept C2780585763 @default.
• W2535014722 hasConcept C501593827 @default.
• W2535014722 hasConcept C523546767 @default.
• W2535014722 hasConcept C54355233 @default.
• W2535014722 hasConcept C71924100 @default.
• W2535014722 hasConcept C81396022 @default.
• W2535014722 hasConcept C86803240 @default.
• W2535014722 hasConcept C89423630 @default.
• W2535014722 hasConcept C90924648 @default.
• W2535014722 hasConceptScore W2535014722C126322002 @default.
• W2535014722 hasConceptScore W2535014722C141071460 @default.
• W2535014722 hasConceptScore W2535014722C2777677444 @default.
• W2535014722 hasConceptScore W2535014722C2778651397 @default.
• W2535014722 hasConceptScore W2535014722C2778980435 @default.
• W2535014722 hasConceptScore W2535014722C2779443120 @default.
• W2535014722 hasConceptScore W2535014722C2779489039 @default.
• W2535014722 hasConceptScore W2535014722C2780585763 @default.
• W2535014722 hasConceptScore W2535014722C501593827 @default.
• W2535014722 hasConceptScore W2535014722C523546767 @default.
• W2535014722 hasConceptScore W2535014722C54355233 @default.
• W2535014722 hasConceptScore W2535014722C71924100 @default.
• W2535014722 hasConceptScore W2535014722C81396022 @default.
• W2535014722 hasConceptScore W2535014722C86803240 @default.
• W2535014722 hasConceptScore W2535014722C89423630 @default.
• W2535014722 hasConceptScore W2535014722C90924648 @default.
• W2535014722 hasIssue "11" @default.
• W2535014722 hasLocation W25350147221 @default.
• W2535014722 hasLocation W25350147222 @default.
• W2535014722 hasLocation W25350147223 @default.
• W2535014722 hasOpenAccess W2535014722 @default.
• W2535014722 hasPrimaryLocation W25350147221 @default.

• next